Astra Kliinik
- Address
- lock Available on a paid plan
Astra Kliinik - Neurological Movement Disorders Research
Astra Kliinik is a clinical research facility specializing in advanced neurodegenerative and autonomic nervous system disorders. The center focuses on investigating novel therapeutic interventions for complex neurological conditions, with particular expertise in Multiple System Atrophy (MSA) and related movement disorders.
- Neurogenic Orthostatic Hypotension (nOH) treatment research
- Multiple System Atrophy clinical trials
- Autonomic dysfunction therapeutics
The research center conducts comprehensive Phase 3 efficacy studies evaluating innovative pharmacological approaches for symptomatic neurogenic orthostatic hypotension in patients with progressive neurological diseases. Their trial protocols incorporate both open-label and double-blind randomized withdrawal designs to assess both therapeutic efficacy and long-term durability of investigational treatments, contributing valuable evidence for managing debilitating autonomic symptoms in neurodegenerative disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 44 other sites in Estonia
Therapeutic Area Benchmark — Estonia
Select a therapeutic area to compare against other sites in Estonia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Estonia
Market Share
Country: Estonia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Astra Kliinik
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Durability of Ampreloxetine in Treating Symptomatic Neurogenic Orthostatic Hypotension in Multiple System Atrophy: A Phase 3 Study | Theravance Biopharma Ireland Limited | Phase III | Not Recruiting | Oct 2023 | Jun 2026 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Ampreloxetine | 1 | Unknown | 2023-10-25 | 2023-10-25 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.